For instance, tumor cells expressing either antigen can be bound and killed separately by CAR T-cells that are designed to target both IL-13Rα2 and B7-H3, an immunological checkpoint protein produced by GBM cells. This evidence concerns the gene IL13RA2 and glioblastoma.